Next-generation sequencing player ArcherDX and precision medicine company HeliTec are teaming up to develop NGS-based cancer diagnostics in China. The pair will work on NGS-based tech and aim to get ...
BOULDER, Colo.--(BUSINESS WIRE)--ArcherDX, Inc. today announced an agreement to develop next-generation sequencing (NGS)-based in vitro diagnostic (IVD) tests with Illumina, Inc. (NASDAQ: ILMN). Under ...
ArcherDX has closed on a $60 million financing round to support its companion diagnostic program spanning solid and blood tumors, as well as circulating tumor DNA tests. The Boulder, Colorado-based ...
BOULDER, Colo., Oct. 3, 2018 /PRNewswire/ -- ArcherDX, a molecular technology company dedicated to developing breakthrough solutions that advance the application of personalized genomic medicine and ...
BOULDER, Colo., Dec. 3, 2019 /PRNewswire/ -- ArcherDX, Inc., a growth-stage molecular diagnostics company dedicated to developing breakthrough solutions that advance personalized genomic medicine, ...
Enzymatics, a Beverly, Mass.-based diagnostics company, has acquired Boulder startup ArcherDx Inc. in a deal with a potential value of about $50 million, officials announced Friday. ArcherDx, formed ...
Horizon Discovery Group plc and ArcherDX, Inc. have announced that they have signed an Original Equipment Manufacture (OEM) agreement that will see Horizon’s Reference Materials supplied as a ...
ArcherDx just got put on the fast track in getting its companion diagnostic on the market. The Boulder, CO-based company said it has been granted a Breakthrough Device Designation for its liquid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results